Carolyn Hamby Shelton

CIK: 0002053473

Transaction Breakdown

Open Market Buys (P)2 (40.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NXL

Nexalin Technology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

NXL
Nexalin Technology, Inc.
Dec 19, 2025
Award(A)
Stock Option (right to buy)*
Direct
100K shares-
NXL
Nexalin Technology, Inc.
Sep 12, 2025
Award(A)
Stock Option (right to buy)
Direct
20K shares-
NXL
Nexalin Technology, Inc.
Mar 12, 2025
Purchase(P)
Indirect
6K shares at avg. $2.20$13K
NXL
Nexalin Technology, Inc.
Nov 7, 2024
Award(A)
Stock Option (right to buy)
Direct
90.6K shares-
NXL
Nexalin Technology, Inc.
Oct 14, 2024
Purchase(P)
Direct
24K shares at avg. $0.85$20K

		Type	Shares	Price		Ownership
Dec 19, 2025	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)*	100,000	-	-	Direct
Sep 12, 2025	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)	20,000	-	-	Direct
Mar 12, 2025	NXL Nexalin Technology, Inc.	Purchase(P)	6,000	$2.20	$13,200	Indirect
Nov 7, 2024	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)	90,620	-	-	Direct
Oct 14, 2024	NXL Nexalin Technology, Inc.	Purchase(P)	24,000	$0.85	$20,400	Direct

1-5 of 5 transactions

About Shelton Carolyn Hamby

Shelton Carolyn Hamby (SEC CIK 0002053473) files insider reports with the SEC as Senior VP of Nexalin Technology, Inc. (NXL).

Signal8 holds 4 ownership filings by Shelton Carolyn Hamby (3 Form 4, 1 Form 5), filed between Feb 10, 2025 and Dec 23, 2025. Those filings report 5 transactions, from Oct 14, 2024 to Dec 19, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Shelton Carolyn Hamby's filings is in BYHALIA, MS.

Recent filings by Shelton Carolyn Hamby

Dec 19, 2025: Grant or award of NXL derivative securities (Form 4, code A).
Sep 12, 2025: Grant or award of NXL derivative securities (Form 4, code A).
Mar 12, 2025: Open-market purchase of NXL shares (Form 4, code P).
Nov 7, 2024: Grant or award of NXL derivative securities (Form 5, code A).
Oct 14, 2024: Open-market purchase of NXL shares (Form 5, code P).

Other insiders filing for Nexalin Technology, Inc. (NXL)

White Mark, President and CEO
Van Fleet Justin, CFO
Owens David, Chief Medical Officer
Hu Ben, Director
Kazden Alan, Director
OSSER LEONARD, 10% Owner

How to read Form 4 transaction codes